Microprocessor-Controlled Prosthetic Knee for Amputation
(MPK-K2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines whether a new type of prosthetic knee, the microprocessor-controlled knee (MPK), provides better physical and psychological benefits than the usual non-microprocessor-controlled knee (NMPK). The MPK automatically adjusts to assist with walking, potentially making movement easier and more comfortable. Veterans with a single, above-the-knee amputation who have used a prosthetic for at least a year and have a good fit and sensation in their current prosthetic leg may qualify for this study. Participants will first be tested using their current NMPK and then with the MPK after a two-month adjustment period. As an unphased trial, this study allows veterans to contribute to innovative research that could enhance prosthetic technology for future users.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this microprocessor-controlled prosthetic knee is safe for use in Veterans with transfemoral amputations?
Research has shown that microprocessor-controlled prosthetic knees (MPKs), such as the College Park ICON, are generally safe for users. These knees automatically adjust to improve walking control, reducing falls and enhancing stability. Studies of individuals with above-the-knee limb loss found that MPKs enhance walking ability without major safety concerns.
Users of MPKs reported feeling more confident and stable while walking, even on uneven surfaces like ramps and stairs. This boost in confidence is important because it can lead to a more active and independent lifestyle. Studies have not commonly reported major negative side effects, suggesting that MPKs are well-tolerated by users.
While MPKs may have some minor issues, evidence suggests they are a safe option for those seeking to improve mobility and quality of life. Discussing specific safety concerns with a healthcare provider is a good next step.12345Why are researchers excited about this trial?
Researchers are excited about the College Park ICON microprocessor-controlled prosthetic knee (MPK) because it offers a significant upgrade over conventional non-microprocessor prosthetic knees (NMPK). Unlike standard prosthetics, which rely on mechanical systems, the ICON MPK uses advanced sensors and microprocessors to adapt in real-time to the user's movements and the terrain. This can result in smoother walking, better stability, and decreased risk of falls, which are major concerns with traditional prosthetic knees. By providing a more natural walking experience, the ICON MPK has the potential to significantly improve the quality of life for individuals with lower limb amputations.
What evidence suggests that this microprocessor-controlled knee is effective for improving mobility in veterans with transfemoral amputations?
Research shows that the College Park ICON MPK, which participants in this trial will use, helps individuals with above-knee amputations walk more naturally. It automatically adjusts to enhance walking and balance. Studies have found that these prosthetic knees improve users' ability to perform daily activities and boost confidence, even on uneven ground, ramps, and stairs. They also reduce strain on the other leg. Overall, these prosthetic knees can enhance both physical ability and mental well-being for those with above-knee amputations.15678
Who Is on the Research Team?
Steven A Gard, PhD
Principal Investigator
Jesse Brown VA Medical Center, Chicago, IL
Are You a Good Fit for This Trial?
This trial is for Veterans with unilateral, transfemoral amputations who are currently using a nonmicroprocessor-controlled knee (NMPK). They should be able to walk at a K2 level, which means they have the ability to traverse low-level environmental barriers such as curbs and stairs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Evaluation
Participants are evaluated using their conventional NMPK to establish baseline measures
Accommodation Period
Participants are fitted with the College Park Icon MPK and allowed a 2-month accommodation period
Post-Accommodation Evaluation
Participants are evaluated after the accommodation period with the MPK to assess changes in mobility and psychological well-being
Follow-up
Participants are monitored for safety and effectiveness after the main evaluation
What Are the Treatments Tested in This Trial?
Interventions
- College Park ICON
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor